Sickle Cell Disease
Sickle Cell Disease (SCD) is an inherited blood disorder that affects red blood cells. This condition is caused by a mutation in the HBB gene, which produces hemoglobin. Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. In individuals with SCD, the hemoglobin is abnormal and causes the red blood cells to become sickle-shaped instead of round. These sickle-shaped cells can become stuck in blood vessels, which can block the flow of oxygen and cause severe pain and damage to organs. Research in hematology and oncology is focused on finding new treatments and therapies for SCD. One approach is through gene therapy, where the mutated HBB gene is replaced with a healthy gene. This treatment is still in the early stages of development but has shown promise in clinical trials. Other treatments for SCD include blood transfusions and bone marrow transplants. Blood transfusions provide healthy red blood cells to replace the sickle cells, while bone marrow transplants involve replacing the patient's bone marrow with healthy donor cells. In addition to finding treatments for SCD, research in hematology and oncology is also focused on understanding the underlying mechanisms of the disease. This includes identifying the triggers that cause sickle cells to form and studying the impact of SCD on other organs in the body. Overall, research in hematology and oncology is critical for improving the lives of individuals with SCD and finding a cure for this debilitating condition.
← Hematology Research and Oncology Research